openPR Logo
Press release

Cystic Fibrosis Market Opportunity Analysis, 2018-2026

09-03-2018 03:39 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF. Some of the other signs and symptoms include sinus infections, poor growth, infertility in males, fatty stool, and guild of the fingers and toes. Different individuals may have diverse degrees of symptoms. CF is chiefly inherited as an autosomal recessive gene. It is triggered by mutations in both the copies of the gene for CFTR or cystic fibrosis transmembrane conductance regulator protein. Individuals with a single copy are carriers. Cystic fibrosis transmembrane conductance regulator protein is involved in the production of digestive fluids, mucus, and sweat. When the protein is not functional, secretions otherwise thin become thick. The ailment is mostly diagnosed by genetic testing and sweat test.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/236

Over the last few years, advancements in technology have resulted in a shift in research and development towards treatments that target the fundamental cause of the disease by targeting the CFTR function. Moreover, there is an affinity towards licensing the products, and for that reason alliances are being made by a number of biotechnology and pharmaceutical manufacturers, since the majority of the treatments for cystic fibrosis are developed by smaller manufacturers. The increase in licensing activity along with the rise in the number of new partnerships will encourage the smaller companies to continue their research work thereby giving a positive momentum to the cystic fibrosis market.

In spite of significant advancement in cystic fibrosis therapeutics, individuals suffering from CF face significant unmet needs owing to the deficiency of restorative therapies, inadequate choice of mucolytic treatments, and the unvarying fight alongside severe lung infection that needs the expansion of novel antibiotics. These factors are likely to drive the growth of the cystic fibrosis market during the forecast period.

There are many types of antibiotics for CF lung infections such as P. aeruginosa and S. aureus. Nevertheless, excessive use of the drug may lead to resistant strains of the gene. Antibiotics are the most common treatment regime in CF, since they are mainly used to eliminate pathogens in recently infected patients. Antibiotics are used on a long-term basis to avoid the requirement of more serious hospital treatments as a result of their ability to control the infection. The requirement for a more wide range of antibiotics is mirrored in the CF treatment market, with more than a few novel antibiotics in active development phase. This dynamic nature of the treatment for CF will encourage the growth of the global CF market.

High prevalence of genetic diseases including CF will drive the overall cystic fibrosis market

According to Netwellness, a community service provider, 3 to 4% of the babies are born with genetic disorders. This number is poised to rise in the coming years, especially in the emerging economies of Asia pacific such as China and India owing to high birth rate observed in these regions. As the number of cases of CF rises, so will the demand for CF treatment, thereby augmenting the growth of the overall cystic fibrosis market during the forecast period.

Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/236

On the basis of geography North America held the maximum market share in the cystic fibrosis market globally. Constructive and favorable regulations and policies as well as high availability of sophisticated healthcare facilities and rising approvals of drugs for treating CF are likely to propel the growth of the cystic fibrosis industry in this region.

Some of the key players operating in the global cystic fibrosis market are AbbVie, Inc., Aradigm, Aurora Biosciences, Bayer AG, Demegen, EryDel, Genentech, Inc., InDex Pharmaceuticals, ManRos Therapeutics, Novartis AG, Polydex Pharmaceuticals, and F. Hoffmann-La Roche AG.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cystic Fibrosis Market Opportunity Analysis, 2018-2026 here

News-ID: 1217201 • Views:

More Releases from Coherent Market Insights

Petrochemicals Market Trends: 1,200 Bn Value Share, Industry Evaluation, and Future Insights By 2024-2031 | BASF SE, Sinopec Limited, ExxonMobil
Petrochemicals Market Trends: 1,200 Bn Value Share, Industry Evaluation, and Fut …
The latest market intelligence report published by CMI with the title "Global Petrochemicals Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Bulk Chemicals industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database. The Research report on Petrochemicals Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also
Diesel Generators Market Trends With CAGR of 5.7% Share Distribution, and Growth Forecast Report 2024 - 2031 | AKSA Power Generation Company, Atlas Copco AB
Diesel Generators Market Trends With CAGR of 5.7% Share Distribution, and Growth …
The diesel generators market is estimated to be valued at USD 20.02 Bn in 2024 and is expected to reach USD 29.51 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031. The latest market intelligence report published by CMI with the title "Global Diesel Generators Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Energy industry. The report provides demand analysis, industry
Metal Additive Manufacturing Market Growing CAGR of 13.7% Assessment, Share Overview, and Growth Projections Report 2024 - 2031 | GE Additive, 3D Systems, Desktop Metal
Metal Additive Manufacturing Market Growing CAGR of 13.7% Assessment, Share Over …
Global metal additive manufacturing market is estimated to be valued at USD 5.85 Bn in 2024 and is expected to reach USD 14.37 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.7% from 2024 to 2031. The latest market intelligence report published by CMI with the title "Global Metal Additive Manufacturing Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Advanced Materials industry. The report provides demand
Mango Seed Oil Market Review, Share Metrics, and Growth Insights Report 2024 - 2031 | VedaOils, Natures Natural India, AG Organica
Mango Seed Oil Market Review, Share Metrics, and Growth Insights Report 2024 - 2 …
The global mango seed oil market is estimated to be valued at USD 237.9 Mn in 2024 and is expected to reach USD 387.1 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. The latest market intelligence report published by CMI with the title "Global Mango Seed Oil Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Agrochemicals industry. The report provides

All 5 Releases


More Releases for Cystic

Cystic Fibrosis Market Report-Growth with Industry Study, Detailed Analysis | Cy …
The research study contains an in detail descriptive overview and analysis of the Cystic Fibrosis Market, a summary of the market shares constituted by each component, the annual growth of each sector, and the revenue potential of the section. In addition, Cystic Fibrosis Market production and consumption data are used to determine the geographical features. Get FREE PDF sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3639856 Top Company Profile Analysis in this Report- Cystic Fibrosis
The Cystic Fibrosis Market to Witness Robust Growth Due to Increasing Cases of C …
Cystic fibrosis is a rare, progressive, life-threatening disease results in the formation of thick mucus that builds up in the lungs, digestive tract, and other parts of the body. If left untreated, it leads to severe digestive and respiratory problems as well as other complications such as infections and diabetes. According to the Cystic Fibrosis Foundation, more than 70,000 people are living with cystic fibrosis around the world. As the
Cystic Fibrosis Therapeutics Market - Forecasts to 2026
As per the research conducted by GME, the Global Cystic Fibrosis Therapeutics Market will grow with a CAGR value of 13.5% by 2026. Cystic fibrosis is becoming more prevalent, resulting in increased awareness, technological improvements, strong pipeline prospects, and expanding R&D initiatives which are some of the factors to influence the growth of the market. The disease has no permanent cure but the symptoms and complications can be reduced by
Cystic Fibrosis - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Cystic Fibrosis - Heat Map and Analysis to its growing collection of premium market research reports. Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body’s epithelial cells, and result in
Cystic Fibrosis - Heat Map And Analysis
MarketResearchReports.Biz is providing you Latest Market Research report of "Cystic Fibrosis - Heat Map And Analysis". Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body?s epithelial cells, and result in the buildup of a thick and sticky mucus in the lungs
Cystic Fibrosis Leadership Council Announces Fundraiser
RALEIGH, N.C. (August 4, 2010) ―The Leadership Council of the YPLC announces today that it is hosting the second annual A Night at the Theatre, Starring Grapes & Hops. The charity event (cff. org/Chapters/carolinas) will be held October 6, 2010 inside the Meymandi Theatre at the Murphey School in Raleigh. Proceeds will benefit the North Carolina chapter of the Cystic Fibrosis Foundation. Festivities will begin at 6:00 p.m. The beer